The current status of treatment for colorectal cancer in China A systematic review

被引：121

作者：

Zhang, Yumei ^{[1
]}

Chen, Zhiyu ^{[2
]}

Li, Jin ^{[1
,3
]}

机构：

[1] Tongji Univ, Dept VIP Clin, South Branch, Shanghai East Hosp, Shanghai, Peoples R China

[2] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai, Peoples R China

[3] Tongji Univ, Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

来源：

MEDICINE | 2017年 / 96卷 / 40期

关键词：

chemotherapy; colorectal cancer; maintenance therapy; radiotherapy; targeted therapy; ADVANCED RECTAL-CANCER; COMPLETE MESOCOLIC EXCISION; RANDOMIZED CONTROLLED-TRIAL; OPEN-LABEL; NEOADJUVANT CHEMOTHERAPY; MAINTENANCE THERAPY; 1ST-LINE TREATMENT; NON-INFERIORITY; OPEN SURGERY; DOUBLE-BLIND;

D O I：

10.1097/MD.0000000000008242

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Colorectal cancer (CRC) is one of the most common cancers all over the world, but its epidemiology is obviously different in various regions. Methods: The treatment of CRC also has varying characteristics due to differences in economy, geography, disease onset, chemotherapy, and other factors, although international guidelines are used to guide the treatment of CRC in China. Results: This paper summarizes the current status of CRC treatment, including surgical therapy, neoadjuvant radiotherapy and chemotherapy, postoperative chemotherapy, targeted therapy, maintenance therapy, and immunotherapy, according to the clinical situation in China, so as to provide better therapy and improve clinical practice for patients with CRC. Conclusion: This research shows that the treatment of colorectal cancer continues to progress, and the patient's efficacy and quality of life have improved.

引用

页数：6

共 63 条

[1] Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials [J].

Arnold, D. ;

Lueza, B. ;

Douillard, J. -Y. ;

Peeters, M. ;

Lenz, H. -J. ;

Venook, A. ;

Heinemann, V. ;

Van Cutsem, E. ;

Pignon, J. -P. ;

Tabernero, J. ;

Cervantes, A. ;

Ciardiello, F. .

ANNALS OF ONCOLOGY, 2017, 28 (08) :1713-1729

[2] Rectal Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines [J].

Benson, Al B., III ;

Venook, Alan P. ;

Bekaii-Saab, Tanios ;

Chan, Emily ;

Chen, Yi-Jen ;

Cooper, Harry S. ;

Engstrom, Paul F. ;

Enzinger, Peter C. ;

Fenton, Moon J. ;

Fuchs, Charles S. ;

Grem, Jean L. ;

Grothey, Axel ;

Hochster, Howard S. ;

Hunt, Steven ;

Kamel, Ahmed ;

Kirilcuk, Natalie ;

Leong, Lucille A. ;

Lin, Edward ;

Messersmith, Wells A. ;

Mulcahy, Mary F. ;

Murphy, James D. ;

Nurkin, Steven ;

Rohren, Eric ;

Ryan, David P. ;

Saltz, Leonard ;

Sharma, Sunil ;

Shibata, David ;

Skibber, John M. ;

Sofocleous, Constantinos T. ;

Stoffel, Elena M. ;

Stotsky-Himelfarb, Eden ;

Willett, Christopher G. ;

Gregory, Kristina M. ;

Freedman-Cass, Deborah .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (06) :719-728

[3] A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer [J].

Cao, Ranhua ;

Zhang, Shuai ;

Ma, Dedong ;

Hu, Likuan .

MEDICAL ONCOLOGY, 2015, 32 (01) :1-5

[4] Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer [J].

Cercek, Andrea ;

Goodman, Karyn A. ;

Hajj, Carla ;

Weisberger, Emily ;

Segal, Neil H. ;

Reidy-Lagunes, Diane L. ;

Stadler, Zsofia K. ;

Wu, Abraham J. ;

Weiser, Martin R. ;

Paty, Philip B. ;

Guillem, Jose G. ;

Nash, Garrett M. ;

Temple, Larissa K. ;

Garcia-Aguilar, Julio ;

Saltz, Leonard B. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (04) :513-519

[5] Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer [J].

Chang, Wenju ;

Wei, Ye ;

Ren, Li ;

Zhong, Yunshi ;

Yu, Yiyi ;

Chen, Jingwen ;

Zhu, Dexiang ;

Ye, Lechi ;

Qin, Chunzhi ;

Zhao, Naiqing ;

Niu, Weixin ;

Qin, Xinyu ;

Xu, Jianmin .

ANNALS OF SURGERY, 2016, 263 (03) :434-439

[6] Cancer Statistics in China, 2015 [J].

Chen, Wanqing ;

Zheng, Rongshou ;

Baade, Peter D. ;

Zhang, Siwei ;

Zeng, Hongmei ;

Bray, Freddie ;

Jemal, Ahmedin ;

Yu, Xue Qin ;

He, Jie .

CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132

[7] Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus [J].

Cheng, Ann-Lii ;

Li, Jin ;

Vaid, Ashok K. ;

Ma, Brigette Buig Yue ;

Teh, Catherine ;

Ahn, Joong B. ;

Bello, Maximino ;

Charoentum, Chaiyut ;

Chen, Li-Tzong ;

Lopes, Gilberto de Lima, Jr. ;

Ho, Gwo F. ;

Kong, Hwai L. ;

Lam, Ka O. ;

Liu, Tian S. ;

Park, Young S. ;

Sriuranpong, Virote ;

Sudoyo, Aru W. ;

Wang, Jaw-Yuan ;

Zhang, Jun ;

Zhang, Su Z. ;

Ciardiello, Fortunato ;

Koehne, Clause-Henning ;

Shaw, Michael ;

Kim, Tae Won .

CLINICAL COLORECTAL CANCER, 2014, 13 (03) :145-155

[8] Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial [J].

Deng, Yanhong ;

Chi, Pan ;

Lan, Ping ;

Wang, Lei ;

Chen, Weiqing ;

Cui, Long ;

Chen, Daoda ;

Cao, Jie ;

Wei, Hongbo ;

Peng, Xiang ;

Huang, Zonghai ;

Cai, Guanfu ;

Zhao, Ren ;

Huang, Zhongcheng ;

Xu, Lin ;

Zhou, Hongfeng ;

Wei, Yisheng ;

Zhang, Hao ;

Zheng, Jian ;

Huang, Yan ;

Zhou, Zhiyang ;

Cai, Yue ;

Kang, Liang ;

Huang, Meijin ;

Peng, Junsheng ;

Ren, Donglin ;

Wang, Jianping .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (27) :3300-+

[9] KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer [J].

Deng, Yanhong ;

Wang, Li ;

Tan, Shuyun ;

Kim, George P. ;

Dou, Ruoxu ;

Chen, Dianke ;

Cai, Yue ;

Fu, Xinhui ;

Wang, Lei ;

Zhu, Jun ;

Wang, Jianping .

MOLECULAR ONCOLOGY, 2015, 9 (07) :1341-1347

[10] Clinical significance of immunotherapy with combined three kinds of cells for operable colorectal cancer [J].

Du, Xiao-Hui ;

Liu, Hai-Liang ;

Li, Li ;

Xia, Shao-You ;

Ning, Ning ;

Zou, Zhen-Yu ;

Teng, Da ;

Xiao, Chun-Hong ;

Li, Rong ;

Xu, Ying-Xin .

TUMOR BIOLOGY, 2015, 36 (07) :5679-5685

← 1 2 3 4 5 6 7 →